Inogen | INGN - Pre Tax Profit


Inogen reported $-6.06M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
Accuray USD 3.23M 6.56M Dec/2024
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 2.36M 2.45M Dec/2025
Baxter International USD 121M 12M Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 938M 3M Sep/2025
Chart Industries USD -182.7M 278.1M Sep/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Dexcom USD 300M 58.9M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 140.2M 17.4M Dec/2025
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Orthofix International USD -2.19M 20.07M Dec/2025
Philips EUR 275M 62M Sep/2025
ResMed USD 482.38M 2.51M Sep/2025
Steris USD 324.4M 92.5M Sep/2025
Stryker USD 1.03B 13M Sep/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
X T L Biopharmaceuticals USD -385K 168K Dec/2024
Zimmer Biomet Holdings USD 418.7M 194.1M Sep/2025